RGDXQ (Response Genetics) Long-Term Debt: $4.64 Mil (As of Dec. 2015)


What is Response Genetics Long-Term Debt?

Response Genetics RGDXQ -98.00% Long-Term Debt is $4.64 Mil as of Dec. 2015.

Response Genetics's Long-Term Debt for the quarter that ended in Dec. 2015 was $4.64 Mil.

Response Genetics's quarterly Long-Term Debt increased from Dec. 2014 ($6.56 Mil) to Mar. 2015 ($10.76 Mil) but then declined from Mar. 2015 ($10.76 Mil) to Dec. 2015 ($4.64 Mil).

Response Genetics's annual Long-Term Debt increased from Dec. 2013 ($1.00 Mil) to Dec. 2014 ($6.56 Mil) but then declined from Dec. 2014 ($6.56 Mil) to Dec. 2015 ($4.64 Mil).

Response Genetics  (OTCPK:RGDXQ) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Response Genetics Long-Term Debt Related Terms

Response Genetics Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Response Genetics's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Response Genetics Long-Term Debt Chart

Response Genetics Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 1.00 6.56 4.64

Response Genetics Quarterly Data
Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Dec15
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.50 9.44 6.56 10.76 4.64
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of $4.64 Mil mean?
Response Genetics (RGDXQ) has a Long-Term Debt of $4.64 Mil as of Dec. 2015.
Is Response Genetics' Long-Term Debt too high?
Response Genetics' current Long-Term Debt is $4.64 Mil.
How does Response Genetics' Long-Term Debt compare to PSID and GBSN?
Response Genetics' Long-Term Debt of $4.64 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Medical Diagnostics & Research company?
A good Long-Term Debt depends on the Medical Diagnostics & Research industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Response Genetics's current Long-Term Debt is $4.64 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Response Genetics stock overvalued right now?
Response Genetics (RGDXQ) has a current Long-Term Debt of $4.64 Mil. The current Long-Term Debt is $4.64 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Response Genetics (RGDXQ), the current Long-Term Debt is $4.64 Mil as of Dec. 2015. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Response Genetics Business Description

Address 201 Route 17 North, 2nd Floor, Rutherford, NJ, USA, 07070
Response Genetics Inc develops and sells diagnostic tests. It provides molecular- and biomarker-based tests and services which enables physicians to personalize the clinical management of each individual patient by providing genomic information to diagnose, monitor and inform cancer treatment. The group generates revenue from providing Biopharma Services, Clinical Services, and Discovery Services, of which majority of the revenue is derived from providing Biopharma Services. Biopharma services provide companies with customized solutions for patient stratification and treatment selection through molecular- and biomarker-based testing services, customized assay development and trial design consultation. The firm operates in the US and internationally and generates prime revenue from the US.